Back
Voyager Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
40
VYGR
Voyager Therapeutics
Last Price:
7.62
Seasonality Move:
2.68%
Sell
11
NBY
NovaBay Pharmaceuticals
Last Price:
0.08
Seasonality Move:
-10.02%
Sell
40
Voyager Therapeutics (VYGR)
is a Sell
Is Voyager Therapeutics a Buy, Sell or Hold?
- The current Voyager Therapeutics [VYGR] share price is $7.42. The Score for VYGR is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- VYGR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
11
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.08. The Score for NBY is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
VYGR Stock Price Chart
What is Voyager Therapeutics's stock price today?
-
The Voyager Therapeutics share price today is $7.42
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VYGR is experiencing slight buying pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.08
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
VYGR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.45 | Sell |
Relative Strength Index (14 RSI): | 34.36 | Sell |
Chaikin Money Flow: | 120177 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.84 - 9.62) | Sell |
Bollinger Bands (100): | (7.46 - 9.26) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 29.5 | Sell |
Chaikin Money Flow: | 117969 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.08 - 0.12) | Sell |
Bollinger Bands (100): | (0.1 - 0.22) | Sell |
VYGR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.62 | Sell |
20-day SMA: | 8.55 | Sell |
50-day SMA: | 8.76 | Sell |
200-day SMA: | 8.23 | Sell |
8-day EMA: | 7.73 | Sell |
20-day EMA: | 8.26 | Sell |
50-day EMA: | 8.51 | Sell |
200-day EMA: | 8.32 | Sell |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.08 | Sell |
20-day SMA: | 0.09 | Sell |
50-day SMA: | 0.12 | Sell |
200-day SMA: | 0.34 | Sell |
8-day EMA: | 0.08 | Sell |
20-day EMA: | 0.09 | Sell |
50-day EMA: | 0.12 | Sell |
200-day EMA: | 0.57 | Sell |
Voyager Therapeutics Earnings Growth & VYGR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.11 per share, a decrease this year of $3.25 per share, and an increase next year of $0.04 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.04 per share, an increase this year of $2.04 per share, and an increase next year of $0.30 per share.
Voyager Therapeutics Technical Analysis
Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |